Journal
CNS NEUROSCIENCE & THERAPEUTICS
Volume 27, Issue 12, Pages 1437-1445Publisher
WILEY
DOI: 10.1111/cns.13743
Keywords
central nervous system diseases; exosome-based therapy; exosomes
Categories
Funding
- National Institute of Neurological Disorders and Stroke [1R01NS102720]
- American Heart Association [18POST33990433]
Ask authors/readers for more resources
Exosomes, secreted by various types of cells, play a crucial role in cell-to-cell communication by delivering proteins and nucleic acids. They are increasingly recognized for their involvement in the pathogenesis of central nervous system diseases and as a promising therapeutic strategy. Research has shown that exosome infusion has beneficial effects on CNS injury animal models, highlighting their potential in neurological medicine.
Exosomes (EXs), a type of extracellular vesicles, are secreted from virtually all types of cells. EXs serve as cell-to-cell communicators by conveying proteins and nucleic acids with regulatory functions. Increasing evidence shows that EXs are implicated in the pathogenesis of central nervous system (CNS) diseases. Moreover, EXs have recently been highlighted as a new promising therapeutic strategy for in vivo delivery of nucleotides and drugs. Studies have revealed that infusion of EXs elicits beneficial effects on the CNS injury animal models. As compared to cell-based therapy, EXs-based therapy for CNS diseases has unique advantages, opening a new path for neurological medicine. In this review, we summarized the current state of knowledge of EXs, the roles and applications of EXs as a viable pathological biomarker, and EX-based therapy for CNS diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available